Live tape
Top 8, mentions 7d29,038NVDA14,057 mentions▲ +0.04ANT3,974 mentions▲ +0.07GOOGL2,835 mentions▲ +0.04SPY2,208 mentions▲ +0.05QQQ1,766 mentions▲ +0.04SPCX1,709 mentions▲ +0.08AMD1,329 mentions▲ +0.06AAPL1,160 mentions▲ +0.04

Equity · Healthcare

BMY

NYSE

Bristol-Myers Squibb Company (BMY)

58.83 USD +0.83% vs prior close Nov 20, 2026
Bristol-Myers Squibb Company price graph
64 sessions
70 55 24 Aug 20 Nov

The line runs 67 USD on 24 August through 58.83 USD on 20 November, on a scale from 55 to 70. Days the market did not trade hold the previous close, flat.

Market cap
120.2B USD
P/E (TTM)
13.0
Revenue, year to Dec 2025
48.2B USD
EPS, diluted, year to Dec 2025
3.46 USD
52-week range
45.79 USD – 68.08 USD
Avg volume
641.1K
Mentions, 30 days
6
Net sentiment
+0.10

as of Nov 20, 2026

Have Bristol-Myers Squibb Company (BMY) insiders bought or sold shares recently?

In the 90 days to 21 Nov 2026, Bristol-Myers Squibb Company insiders reported 3 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 10 Mar 2026, show no open-market purchase.

Form 4, 90 days to 21 Nov 2026, newest reported trade 5 Nov 2026

0buys
3sells
$678Knet sold
13other filings
Have Bristol-Myers Squibb Company (BMY) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
05 Nov 2026Haller Julia ADirectorSell3,800241K USD
09 Sep 2026Massacesi CristianEVP,Chief Med Offr,Head of DevSell6,249403K USD
25 Aug 2026Holzer Phil MSVP and ControllerSell50034K USD
Sold3 open-market sales10,549$678K
13 other filings in the window: grants, exercises, tax withholding and transfers, not trades
Have Bristol-Myers Squibb Company (BMY) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
03 Nov 2026Lenkowsky AdamEVP, Chief Commercial OfficerOption exercise7,522
03 Nov 2026Lenkowsky AdamEVP, Chief Commercial OfficerTax withheld3,848237K USD
01 Nov 2026BOERNER CHRISTOPHER S.Chief Executive OfficerOption exercise2,964
01 Nov 2026BOERNER CHRISTOPHER S.Chief Executive OfficerOther406
01 Nov 2026BOERNER CHRISTOPHER S.Chief Executive OfficerTax withheld1,724108K USD
01 Nov 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.Option exercise6,281
01 Nov 2026Meyers Gregory ScottEVP, Chief Digital & Tech Off.Tax withheld2,665167K USD
01 Nov 2026Shanahan KarinEVP, Chief Supply Chain & OpsOption exercise6,281
01 Nov 2026Shanahan KarinEVP, Chief Supply Chain & OpsTax withheld3,213201K USD
02 Oct 2026Gallman CariEVP, General CounselOption exercise4,559
02 Oct 2026Gallman CariEVP, General CounselTax withheld2,332143K USD
01 Sep 2026Short Bartie WendyEVP, Corporate AffairsOption exercise1,23683K USD

Showing the 12 most recent of 13 compensation filings in this window. The figures above count all of them.

Which funds hold Bristol-Myers Squibb Company (BMY)?

14 of the 45 institutional funds we track reported a Bristol-Myers Squibb Company position for the quarter ended 30 Sep 2026 — a combined 2.7B USD; the latest of those filings landed 16 Nov 2026.

Form 13F

Which funds hold Bristol-Myers Squibb Company (BMY)?
FundPositionSharesValueShares q/q
AQR Capital ManagementHeld (±25%)24,884,5061.6B USD−9.0%
Two Sigma InvestmentsHeld (±25%)7,879,742491.7M USD−21.9%
Man GroupHeld (±25%)4,209,775262.7M USD−10.1%
Millennium ManagementAdded2,203,471137.5M USD+192.8%
D. E. Shaw & Co.Added1,146,29771.5M USD+104.9%
Citadel AdvisorsTrimmed1,142,91471.3M USD−27.3%
Tudor Investment CorpNew position1,033,78864.5M USD
Fisher Asset ManagementHeld (±25%)213,13113.3M USD+22.9%
Balyasny Asset ManagementHeld (±25%)97,8486.1M USD+10.8%
GAMCO InvestorsHeld (±25%)82,0735.1M USD−0.7%

Showing the 10 largest of 14 reported positions. The figures above count all of them.

Have members of Congress traded Bristol-Myers Squibb Company (BMY)?

The most recent congressional trade disclosed in Bristol-Myers Squibb Company is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 19 Dec 2025.

STOCK Act disclosures

Have members of Congress traded Bristol-Myers Squibb Company (BMY)?
TradedMemberTypeAmountFiled after
19 Dec 2025Gilbert Ray Cisneros, Jr.house · Democrat–CAPurchase1K USD–15K USD24 days
18 Dec 2025Julie Johnsonhouse · Democrat–TXSale1K USD–15K USD28 days
13 Nov 2025Julie Johnsonhouse · Democrat–TXSale1K USD–15K USD28 days
12 Nov 2025Gilbert Ray Cisneros, Jr.house · Democrat–CAPurchase1K USD–15K USD33 days
14 Aug 2025Julie Johnsonhouse · Democrat–TXSale1K USD–15K USD28 days
24 Jun 2025Virginia Foxxhouse · Republican–NCSale1K USD–15K USD9 days
12 May 2025Jefferson Shrevehouse · Republican–INSale15K USD–50K USD41 days
28 Apr 2025Julia Letlowhouse · Republican–LASale1K USD–15K USD260 days

Bristol-Myers Squibb Company (BMY) US federal contracts

US federal agencies committed 8.8M USD in contracts to Bristol-Myers Squibb Company (BMY) in fiscal 2026, the year to 30 Sep 2026, against 7.6M USD the year before.

USAspending.gov

1.0MUSDfiscal 2027 so far
8.8MUSDfiscal 2026
7.6MUSDfiscal 2025
3.4MUSDfiscal 2024
Bristol-Myers Squibb Company (BMY) US federal contracts
SignedAgencyContractCommitted
01 Oct 2026Department of Veterans AffairsCAMZYOS AND POMALYSTDRUGS AND BIOLOGICALS · 36C24527N00331.0M USD
06 Aug 2026Department of Veterans AffairsBREYANZI INJECTIONDRUGS AND BIOLOGICALS · 36C24926N0658364K USD
06 Aug 2026Department of Veterans AffairsABECMA INJECTIONDRUGS AND BIOLOGICALS · 36C24926N0651379K USD
02 Aug 2026Department of Veterans AffairsPOMALYST 2 MG, 3 MG,4 MGDRUGS AND BIOLOGICALS · 36C24526N0790199K USD
02 Aug 2026Department of Veterans AffairsMAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST)DRUGS AND BIOLOGICALS · 36C24526N0776300K USD
07 Jul 2026Department of Veterans AffairsPOMALYST 2 MG, 3 MG,4 MGDRUGS AND BIOLOGICALS · 36C24526N0715138K USD
16 Jun 2026Department of Veterans AffairsBREYANZI CAR T - TRANSPLANTDRUGS AND BIOLOGICALS · 36C24926N0591364K USD
16 Jun 2026Department of Veterans AffairsBREYANZI CAR T - TRANSPLANTDRUGS AND BIOLOGICALS · 36C24926N0590364K USD
16 Jun 2026Department of Veterans AffairsBREYANZI CAR TDRUGS AND BIOLOGICALS · 36C24926N0589364K USD
02 Jun 2026Department of Veterans AffairsBREAYNAZI FOR CAR-T TRANSPLANT MEDICATIONDRUGS AND BIOLOGICALS · 36C24926N0433364K USD

Newest first: 10 of 62 contracts. Contracts of US$100,000 or more signed since April 2022; the amount is what the government has committed so far, which grows when options are exercised. Defense Department contracts are published about 90 days after signing, so the latest year is still filling in.

What has been filed or recorded for Bristol-Myers Squibb Company (BMY)?

The filings we hold for Bristol-Myers Squibb Company, newest first: 14 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Oct 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Bristol-Myers Squibb Company (BMY)?
And
30 Oct 2026Fails to deliverShares failed to deliver27 shares2K USD notional · <0.001% of shares out
29 Oct 2026Fails to deliverShares failed to deliver29 shares2K USD notional · <0.001% of shares out
28 Oct 2026Fails to deliverShares failed to deliver61 shares4K USD notional · <0.001% of shares out
26 Oct 2026Fails to deliverShares failed to deliver2 shares123 USD notional · <0.001% of shares out
23 Oct 2026Fails to deliverShares failed to deliver42,277 shares2.7M USD notional · 0.002% of shares out
21 Oct 2026Fails to deliverShares failed to deliver28 shares2K USD notional · <0.001% of shares out
19 Oct 2026Fails to deliverShares failed to deliver289 shares17K USD notional · <0.001% of shares out
16 Oct 2026Fails to deliverShares failed to deliver1,248 shares76K USD notional · <0.001% of shares out
15 Oct 2026Fails to deliverShares failed to deliver998 shares59K USD notional · <0.001% of shares out
14 Oct 2026Fails to deliverShares failed to deliver909 shares52K USD notional · <0.001% of shares out
13 Oct 2026Fails to deliverShares failed to deliver4,894 shares282K USD notional · <0.001% of shares out
09 Oct 2026Fails to deliverShares failed to deliver181 shares11K USD notional · <0.001% of shares out
08 Oct 2026Fails to deliverShares failed to deliver815 shares49K USD notional · <0.001% of shares out
07 Oct 2026Fails to deliverShares failed to deliver6,644 shares396K USD notional · <0.001% of shares out
30 Sep 2026Quarterly earningsQ3 2026 reportedEPS 1.05 USDRevenue $13.07B
30 Sep 2026FinancialsTotal assets88.8B USDat period end
30 Sep 2026FinancialsTotal equity23.4B USDat period end
30 Jun 2026Quarterly earningsQ2 2026 reportedEPS 1.62 USDRevenue $12.97B
31 Mar 2026Quarterly earningsQ1 2026 reportedEPS 1.31 USDRevenue $11.49B
31 Dec 2025Annual reportFY 2025 reportedEPS 3.46 USDRevenue $48.19B
31 Dec 2025FinancialsRevenue48.2B USDfiscal year
31 Dec 2025FinancialsNet income7.1B USDfiscal year
31 Dec 2025FinancialsDiluted EPS3.46 USDfiscal year
30 Sep 2025Quarterly earningsQ3 2025 reportedEPS 1.08 USDRevenue $12.22B
30 Jun 2025Quarterly earningsQ2 2025 reportedEPS 0.64 USDRevenue $12.27B
31 Mar 2025Quarterly earningsQ1 2025 reportedEPS 1.20 USDRevenue $11.20B
31 Dec 2024Annual reportFY 2024 reportedEPS −4.41 USDRevenue $48.30B

What is Reddit saying about Bristol-Myers Squibb Company (BMY)?

Reddit mentioned BMY 6 times in the 30 days to 21 November 2026, across 2 of the communities we track. All of them were scored for sentiment: 83% read bullish, 0% bearish and 17% neither. Reddit data updated 21 November 2026.

30-day window, Method

6mentions, 30 days
83%bullish
0%bearish
2communities
+31pointsagainst the market

How do Reddit mentions of Bristol-Myers Squibb Company (BMY) compare with its price?

Share ↗
6 mentions

Which subreddits are talking about Bristol-Myers Squibb Company (BMY)?

30 days

Which subreddits are talking about Bristol-Myers Squibb Company (BMY)?
CommunityShareMentionsNet sentiment
r/wallstreetbets67%4+0.11
r/investing33%2+0.10

What do people ask about Bristol-Myers Squibb Company (BMY)?

From live data
What did Bristol-Myers Squibb Company shares close at?58.83

Bristol-Myers Squibb Company closed at 58.83 USD on 20 Nov 2026, up 0.83% on the close before. That is the end-of-day price from Finazon, not a live quote.

What is Bristol-Myers Squibb Company’s market cap?120.2B

Bristol-Myers Squibb Company is worth 120.2B USD by market value as of 20 Nov 2026, which is the share price times the shares on issue from its SEC filings.

What is Bristol-Myers Squibb Company’s P/E ratio?13.0

Bristol-Myers Squibb Company has a price-to-earnings ratio of 13.0, as of 20 Nov 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.

What is Bristol-Myers Squibb Company’s revenue?48.2B

Bristol-Myers Squibb Company reported revenue of 48.2B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings

Have Bristol-Myers Squibb Company insiders bought or sold shares recently?3 sales

In the 90 days to 21 Nov 2026, Bristol-Myers Squibb Company insiders reported 3 open-market sales and no purchases (SEC Form 4); the filings we hold, back to 10 Mar 2026, show no open-market purchase. A further 13 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders

Which funds own Bristol-Myers Squibb Company?14 of 45

14 of the 45 funds we track reported a Bristol-Myers Squibb Company position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were AQR Capital Management, Two Sigma Investments and Man Group. See Funds

Have members of Congress traded Bristol-Myers Squibb Company?26 trades

Yes. 26 trades in Bristol-Myers Squibb Company appear in the congressional disclosures we hold; the latest is a purchase by Gilbert Ray Cisneros, Jr. (House, CA) dated 19 Dec 2025, filed 12 Jan 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

When did Bristol-Myers Squibb Company last report earnings?1.05

Bristol-Myers Squibb Company last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 1.05 USD; no next date is announced in SEC filings yet. See Filings

Does Bristol-Myers Squibb Company have government contracts?8.8M

Yes. US federal agencies committed 8.8M USD in contracts to it in fiscal 2026, the year to 30 Sep 2026 (USAspending.gov). See Contracts

What is Reddit saying about Bristol-Myers Squibb Company?0 mentions

Bristol-Myers Squibb Company was mentioned 0 times in the last 7 days across the finance subreddits we track, and 6 times over the trailing 30 days. Of the 6 mentions scored for sentiment, 83% read bullish and 0% bearish. That is a social signal, not investment advice. See Reddit

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. RedditReddit ingest across the tracked finance subreddits
  4. SEC EDGARForm 4 filings (insider transactions)
  5. SEC EDGAR13F filings
  6. Wikimedia CommonsPortraits via Wikimedia Commons. Jefferson Shreve: House Creative Services, Public domain; Julia Letlow: U.S. House of Representatives, Public domain; Virginia Foxx: United States Government, Public domain; Gilbert Ray Cisneros, Jr.: United States Department of Defense, Public domain.
  7. House disclosuresU.S. House of Representatives financial disclosures
  8. USAspendingUSAspending.gov (U.S. Department of the Treasury), federal prime contract awards
  9. SECSEC fails-to-deliver (CNS) data
  10. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  11. SEC EDGARreported earnings figures and scheduled report dates
  12. SEC EDGARValuation computed from SEC EDGAR filings
  13. Wikipediatext of the lead paragraph, licensed CC BY-SA 4.0 (https://creativecommons.org/licenses/by-sa/4.0/) — https://en.wikipedia.org/wiki/Bristol_Myers_Squibb